LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
SK-BR-3 Selumetinib
0.12
uM
LJP6
1.0239 0.0063 1.0368 0.0050
SK-BR-3 Selumetinib
0.37
uM
LJP6
1.0290 0.0065 1.0439 0.0055
SK-BR-3 Selumetinib
1.11
uM
LJP6
1.0095 0.0206 1.0196 0.0303
SK-BR-3 Selumetinib
3.33
uM
LJP6
1.0164 0.0154 1.0214 0.0188
SK-BR-3 Selumetinib
10
uM
LJP6
0.9817 0.0125 0.9687 0.0198
SK-BR-3 MK2206
0.04
uM
LJP6
0.8419 0.0555 0.7608 0.0710
SK-BR-3 MK2206
0.12
uM
LJP6
0.7478 0.0387 0.6035 0.0483
SK-BR-3 MK2206
0.37
uM
LJP6
0.6777 0.0177 0.4844 0.0344
SK-BR-3 MK2206
1.11
uM
LJP6
0.6441 0.0255 0.4294 0.0276
SK-BR-3 MK2206
3.33
uM
LJP6
0.5598 0.0179 0.2827 0.0340
SK-BR-3 MK2206
10
uM
LJP6
0.3704 0.0345 -0.0652 0.0087
SK-BR-3 AZD-6482
0.04
uM
LJP5
0.9919 0.0049 0.9875 0.0072
SK-BR-3 AZD-6482
0.12
uM
LJP5
0.9399 0.0304 0.9154 0.0363
SK-BR-3 AZD-6482
0.37
uM
LJP5
0.9981 0.0322 1.0002 0.0444
SK-BR-3 AZD-6482
1.11
uM
LJP5
0.9080 0.0357 0.8698 0.0413
SK-BR-3 AZD-6482
3.33
uM
LJP5
0.6241 0.0054 0.4043 0.0453
SK-BR-3 AZD-6482
10
uM
LJP5
0.3372 0.0318 -0.1069 0.1198
SK-BR-3 NU7441
0.04
uM
LJP5
1.0313 0.0147 1.0443 0.0211
SK-BR-3 NU7441
0.12
uM
LJP5
0.9688 0.0160 0.9568 0.0199
SK-BR-3 NU7441
0.37
uM
LJP5
0.9125 0.0193 0.8675 0.0354
SK-BR-3 NU7441
1.11
uM
LJP5
0.8170 0.0510 0.7144 0.0879
SK-BR-3 NU7441
3.33
uM
LJP5
0.7655 0.0293 0.6441 0.0475
SK-BR-3 NU7441
10
uM
LJP5
0.4957 0.0506 0.1986 0.0443
SK-BR-3 OSI-027
0.04
uM
LJP6
0.8399 0.0580 0.7599 0.0660
SK-BR-3 OSI-027
0.12
uM
LJP6
0.5800 0.0505 0.3216 0.0390